Emerging New Serotype <i>Lactococcus garvieae </i>Infection in Farmed Marine Fish in Japan

DOI JASI Web Site Web Site 5 Citations 13 References

Bibliographic Information

Other Title
  • 日本の海産養殖魚で発生した新血清型<i>Lactococcus garvieae</i>感染症
  • 日本の海産養殖魚で発生した新血清型Lactococcus garvieae感染症
  • ニホン ノ カイサン ヨウショクギョ デ ハッセイ シタ シン ケッセイガタ Lactococcus garvieae カンセンショウ
Published
2023-12-15
Resource Type
journal article
DOI
  • 10.3147/jsfp.58.146
Publisher
The Japanese Society of Fish Pathology

Search this article

Description

<p>Mortalities due to Lactococcus garvieae-like infection have been observed in farmed greater amberjack Seriola dumerili previously immunized with a commercial L. garvieae vaccine containing serotype I and II strains in Miyazaki Prefecture since August 2021. ​The isolates from diseased fish were not agglutinated by the anti-serotype I and II sera, and showed genetic similarity to L. garvieae serotype I in multi-locus sequence (16S rRNA gene, pheS, recA, rpoA and rpoB) analysis. ​The pathogenicity of isolates was confirmed by intraperitoneal injection in greater amberjack, and the lethal dose fifty was less than 1.6 × 103 CFU/FISH. ​In a vaccine trial, greater amberjack, which had been immunized with formalin-killed cells (FKC) prepared from both serotype I and II strains, was not effectively protected against an isolate from this study, whereas those immunized with FKC prepared using the isolate were effectively protected against the infection with an isolate exhibiting the same antigenicity. ​Based on these findings, we propose a new serotype: serotype III, which is not agglutinated with both anti-serotype I and II serum and not protected against a serotype I and serotype II-combined vaccine.</p>

Journal

  • Fish Pathology

    Fish Pathology 58 (4), 146-152, 2023-12-15

    The Japanese Society of Fish Pathology

Citations (5)*help

See more

References(13)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top